Coronavirus 2020 FEATURED Health Videos

Quick Rundown on Moderna, RNA & mRNA Vaccines: What Are They & Why Should You Care?

Originally posted by Haley Kennington on Kennington Press May 7th, 2020.

Looking into the future, towards what Bill Gates has referred to as potential “miracle vaccines” it’s important to understand why there are concerns by many that toying with vaccines (that have never been able to prevent a disease) is now being looked at as the savior of the current COVID-19 pandemic we’re facing.

University of Cambridge PHG Foundation describes how RNA and mRNA vaccines differ from conventional vaccines:

SOURCE: Cambridge PHG Foundation

Source: Moderna

According to Moderna, “mRNA is the set of instructions by which cells make all proteins and send them to various parts of the body.”

What does mRNA do exactly? Enzymes transcribe DNA templates into strands of mRNA, which are then formulated into lipid nanoparticles. These instructions will change your DNA.

Source: Moderna

“mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases.”


I highly recommend if you’re interested in an even more detailed expansion on mRNA vaccines to see Nature Reviews Drug Discovery review article here.

Also, here’s the WHITE PAPER from Moderna on mRNA vaccines (2017).

Dr. Judy Mikovits, which I will be going into in a future article, lays out exactly why the “miracle vaccine” theory is bound to fail here:

Dr. Judy Mikovits explains COVID-19

RELATED: WATCH: The Video YouTube Doesn’t Want You To See Plandemic Part 1: Dr. Judy Mikovits


“mRNA is the software of life.”

Stephen Hoge, president, Moderna

Moderna describes their past research on coronavirus vaccines in humans, on their website:

“We had previously collaborated with the NIH on a vaccine for MERS-CoV, which is a different type of coronavirus than the current pandemic. While the program was only at the research stage, it provided significant insights as we launched our efforts for mRNA-1273. Before the Phase 1 study for mRNA-1273, we had not previously tested a coronavirus vaccine in humans.”

Moderna CEO Stephane Bancel told “Mad Money” host Jim Cramer from CNBC in January 2020 that they use Amazon Web Services to compare every sequence of a patient’s DNA by way of AWS Cloud Services. “mRNA is like software,” he explained.

Bancel goes into detail on how mRNA can be used as a vaccine in this 2013 TED Talk:

BioTech firm Moderna, which Gates specifically names in the blog post is the first company to start phase 1 of human trials (in March 2020) on an mRNA vaccine named mRNA 1273.

According to, “mRNA-1273 is an mRNA vaccine against SARS-CoV-2 encoding for a prefusion stabilized form of the Spike (S) protein, which was selected by Moderna in collaboration with investigators from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), a part of NIH. Manufacture of the first clinical batch was funded by the Coalition for Epidemic Preparedness Innovations (CEPI).”

Dr. Anthony Fauci has been director of NIAID since 1984. I’ll give you a second to let that sink in.

Not only that, but in a 2010 press release Bill and Melinda Gates announced the “Decade of Vaccines” collaboration between The World Health Organization (WHO), UNICEF, the National Institute of Allergy and Infectious Diseases (NIAID) and the Bill and Melinda Gates Foundation.

RELATED: COVID-19 Researcher Shot Dead in Murder-Suicide in Pennsylvania

January 11th – Chinese authorities shared the genetic sequence of the novel coronavirus

January 13th – the VRC and Moderna’s infectious disease research team finalized the sequence for the SARS-CoV-2 vaccine and Moderna mobilized toward clinical manufacture

February 7th – first clinical batch was completed & underwent analytical testing

February 24th – shipped from Moderna and delivered to NIH from the Company’s manufacturing facility in 42 days from sequence selection.

Essentially, your body will connect to the Cloud. If information can transfer to the Cloud, it can also download information or programs from the Cloud, in addition to permanently changing your DNA.

Michael Watson, President of Valera, a Moderna Venture describes mRNA vaccines as “digitilizing vaccines” in this 2017 clip:

April 16th – Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,000-times-more-potent-

On May 1st, Moderna announced their 10-year plan with Lonza LTD. to develop larger scale manufacture of Moderna’s mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2) as well as a more extensive list of Moderna products.

The terms of the agreement: “to establish manufacturing suites at Lonza’s facilities in the United States and Switzerland for the manufacture of mRNA-1273 at both sites. Technology transfer is expected to begin in June 2020, and the companies intend to manufacture the first batches of mRNA-1273 at Lonza U.S. in July 2020. Over time, the parties intend to establish additional production suites across Lonza’s worldwide facilities, ultimately allowing for the manufacture of material equivalent to up to 1 billion doses of mRNA-1273 per year for use worldwide assuming the currently expected dose of 50 µg. The manufacturing facilities at Lonza complement Moderna’s ongoing U.S. manufacturing efforts, which continue to ramp up to prepare for the further clinical development and commercialization of mRNA-1273.”

The Moderna/Lonza partnership to ramp up the development of mRNA-1273 is funded in part by a recent contract agreement between Moderna and Biomedical Advanced Research and Development Authority (BARDA). part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, which was announced April 16, 2020. 

On April 27th, 2020 Moderna/Lonza submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to move into Phase 2 of the vaccine mRNA-1273 as long as Phase 1 passed all safety protocols.

Phase 1 of the human trial for mRNA-1273 is described by Moderna on their site as:

“An open-label Phase 1 study of mRNA-1273 is being conducted by the National Institute of Allergy and Infectious Diseases under its own Investigational New Drug (IND) application in the U.S. The Phase 1 study, which began on March 16, 2020, completed enrollment of 45 healthy adult volunteers ages 18 to 55 years in the original three dose cohorts (25 µg, 100 µg and 250 µg). The study is enrolling an additional six cohorts: three cohorts of older adults (ages 56-70) and three cohorts of elderly adults (ages 71 and above). Data from the original cohort of healthy adult volunteers ages 18 to 55 years will be reported once available.”

TRENDING: Did China Just Admit the Obama Administration Funded $3.7 Mil for COVID-19 Development?

We’ve just scratched the surface on understanding the complexity of RNA and mRNA vaccines. In the meantime, I strongly urge you to watch the following video before it is pulled from YouTube as dozens and dozens of videos of Dr. Judy Mikovits explaining COVID-19 and exposing Dr. Anthony Fauci have been pulled in the past few weeks.

This story continues to develop. Follow Kennington Press for the latest.

I am 100% reader funded, so please help me continue to bring the information the mainstream media won’t cover to you!

If you enjoy my work, please consider donating via VenmoPayPal, or CashApp.

Related posts

Was Amazon/WaPo Source of Varsity Blues Investigation?


SICK: More Decomposing Children and Fetuses Located in Detroit, Tied to Perry Funeral Home

Haley Kennington

The Majority Has Spoken with their Wallet